HCD122 News
Most Popular HCD122 Story
Xoma, Novartis restructure vaccine agreement
California-based Xoma is restructuring its collaboration pact with Novartis Vaccines and Diagnostics. As part of the updated pact, Xoma gets an up-front payment of $6.2 million. Novartis has also Read more...
Latest Headlines
- November 10, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
